For pharmacy decision-makers focused on operational efficiency and patient safety, Fagron Sterile Services US (FSS) represents a proven partner in 503B outsourcing. As a globally integrated, FDA-registered, and DEA-licensed outsourcing facility, FSS is dedicated to delivering high-quality sterile medications to healthcare facilities across all 50 states. Their product portfolio supports a broad spectrum of patient care needs—including critical care, labor and delivery, ophthalmics, pain management, and more—allowing pharmacy leaders to reduce in-house compounding demands while maintaining compliance with stringent cGMP standards.
FSS’s approach to 503B outsourcing is built around supply chain resiliency and transparency. They collaborate with healthcare providers, health systems, and state and national stakeholders to strengthen sourcing strategies and support uninterrupted medication access. As part of the global Fagron network, FSS combines local expertise with global innovation to provide reliable, ready-to-administer sterile medications. Their outsourcing model is designed to help pharmacy teams mitigate staffing shortages, navigate compliance challenges, and maintain patient care continuity.
Key Highlights of FSS’s 503B Outsourcing Capabilities:
- FDA-Registered, DEA-Licensed, cGMP-Compliant Facilities
- Broad Portfolio of Sterile Medications for critical care, labor and delivery, ophthalmics, pain management, and specialty needs
- Transparent Customer Relationships to support compliance audits and regulatory requirements
- Global Supply Network: Supporting over 700 healthcare providers across 30+ countries
- Experienced Team: 400+ pharmaceutical professionals and 100+ quality experts
For pharmacy leaders seeking a dependable 503B outsourcing partner, Fagron Sterile Services US offers a model focused on safety, compliance, and supply chain resiliency. Learn more and access their product catalog at fagronsterile.com.
